You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
九洲藥業(603456.SH)完成收購蘇州諾華100%股權
格隆匯 12-20 16:21

格隆匯12月20日丨九洲藥業(603456.SH)公佈,公司於2019年9月4日召開第六屆董事會第十七次會議審議通過了《關於擬收購蘇州諾華製藥科技有限公司100%股權的議案》。在標的公司審計工作完成後,公司於2019年11月29日、2019年12月16日,召開第六屆董事會第二十次會議、2019年第一次臨時股東大會,會議審議通過了《關於對外投資收購蘇州諾華製藥科技有限公司100%股權的議案》,同意公司依照與Novartis International Pharmaceutical Investment Ltd.(諾華國際製藥投資有限公司,以下簡稱“諾華投資”)簽署的《股權收購協議》,收購諾華投資所持有的剝離技術與藥品開發資產後的蘇州諾華製藥科技有限公司(以下簡稱“蘇州諾華”)100%股權。

截止本公告披露日,諾華投資已完成蘇州諾華的資產剝離工作,同時雙方已按照《股權收購協議》的相關約定,進行了交易交割,蘇州諾華已成為公司全資子公司,並將納入公司合併報表範圍。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account